Pharmacy Retailing in the UK - Verdict Sector Report

Pharmacy Retailing in the UK - Verdict Sector Report

  • Products Id :- VR0019SR
  • |
  • Pages: 57
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

The UK pharmacy market has continued its recovery in 2014, increasing its estimated value by 2.1%, the fastest rate of growth since 2010. This has been driven by the OTC market, which grew nearly 4%, outperforming the larger NHS receipts component. The OTC market has been lifted by improvements in consumer confidence, with people more willing to spend on self-care, health and wellbeing.

Key Findings

Understand the impact on pharmacy retailing of the Boots/Walgreens merger and how it will increase competitiveness in the sector

Use the detailed data and insight on the market, including NHS receipts and OTC, to help form an effective growth strategy

Idenitfy the opportunities to grow business in this sector by comparing strategies of the key players in the market and their performance metrics

Learn how the UK's ageing population and rising obesity levels will impact the market, allowing you to develop product ranges that are better targeted


The longer-term trend toward reclassification of medicines from prescription only to P category and from P to GSL has continued, supporting pharmacy growth outside the prescription market. As the government seeks to limit NHS budgets and promote self-care, the outperformance of OTC relative to NHS prescriptions is expected to continue.

The end of the 100-hour control of entry exemption, which had been a significant driver of growth in pharmacy numbers, has begun to have an impact on the market, with far more marginal growth in numbers in 2014. Pharmacy numbers have grown by nearly 20% in 10 years, increasing competition, particularly from smaller operators, including the grocers.

The pressure on NHS budgets is likely to continue over the next five years and this will mean that pharmacy's core prescription medicines business will grow only slowly in value if not in volume. The NHS is increasingly looking at using pharmacies to increase its cost effectiveness as well as extending their role in promoting healthy living.

Reasons To Buy

What are the factors that will impede or maxmise future growth opportunities and sales in pharmacy retailing?

Which retailers are gaining market share, and which are struggling to protect their share and why?

How are grocers and local GPs threatening pharmacy specialists and how can retailers deal with these threats and increase customer loyalty?

What impact is government strategy having on the market and how can this be managed to ensure success?

What services are pharmacy specialists investing in, and will these release pressure on GP's and emergency care providers?

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


1 Outlook

1.1 Overview

1.2 Key Findings

1.2.1 Market sees fastest growth since 2010

1.2.2 End of 100-hour control of entry exemption slows store increase

1.2.3 LloydsPharmacy gains ground on market leader Boots

1.2.4 Grocers will continue to grow but at a slower pace

1.2.5 Impact of takeovers likely to strengthen power of leaders Boots and loydsPharmacy

1.2.6 Pharmacy market could see introduction of US-style drugstore formats

1.2.7 NHS cost pressures likely to lead to growth of pharmacy services role

1.2.8 Retailers should invest in stores and technology to build OTC and service revenues

2 Recommendations

2.1 Overview

2.2 Strategic Opportunities

2.2.1 Segmenting store appeal would pay dividends with customers

2.2.2 Use technology to handle increasing prescription volumes

2.2.3 Store innovation will help boost both services and OTC sales

2.2.4 Evidence needed to build arguments for wider health role

2.2.5 Work with new commissioning bodies

2.2.6 Invest in marketing pharmacies' health expertise to consumers

3 Market Size

3.1 Overview

3.2 Pharmacy Market Definition

3.3 Expenditure Trends

3.3.1 Market returns to slow growth

3.3.2 Dominant NHS revenue source sees little increase

3.3.3 Growth in prescriptions per pharmacy recovers

3.3.4 Pharmacy underperforms wider retail sector

3.3.5 OTC sustains market as NHS receipts per head decline

3.4 Market Drivers

3.4.1 Growth in over 75s will drive prescription volumes

3.4.2 Pressures on NHS will lead to increase in pharmacy services

3.4.3 Potential negatives from CCGs and devolved administrations

3.4.4 Increasing emphasis on self-care and recovering disposable incomes to boost OTC

4 Channel Shares

4.1 Overview

4.2 Channels of Distribution

4.2.1 Growth in pharmacy numbers falls back

4.2.2 Specialists hold on to leadership of market

5 Market Shares

5.1 Overview

5.2 Company Market Shares

5.2.1 LloydsPharmacy narrows gap with Boots with share rebound in 2014

5.2.2 Boots strong in both pharmacy and health & beauty

5.2.3 Winners and losers

5.3 Key Operating Statistics

5.3.1 Space

5.3.2 Space productivity

6 Sector Trends

6.1 Overview

6.2 Pharmacy Numbers

6.3 The Future Role of Pharmacies

6.4 Online

6.5 Mergers and Acquisitions

6.6 Grocers

6.7 Format Development

7 Methodology

7.1 Methodology: Outlook

7.1.1 Market size

7.1.2 Market shares

7.1.3 Sales density calculation

7.2 Methodology: Market Size

7.2.1 Market size

7.2.2 Market shares

7.3 Methodology: Channel Shares

7.4 Methodology: Market Shares

7.4.1 Market size

7.4.2 Market shares

7.4.3 Sales density calculation

7.5 Methodology: Sector Trends

7.5.1 Market size

7.5.2 Market shares

8 Appendix

8.1 Appendix: Market Size

8.1.1 Current prices

8.1.2 Inflation

8.1.3 Constant prices

8.1.4 Total growth

8.1.5 Volume growth

8.2 About Verdict Retail

8.3 Disclaimer

Figure 1: Retail pharmacy market growth vs total retail (%), 2009-14e

Figure 2: Population growth by age band (%), 2013-22

Figure 3: Change in number of pharmacies by channel group (%), 2014e on 2009

Figure 4: Market share by channel group (%), 2009-14e

Figure 5: Health & beauty and pharmacy market shares (%), 2014

Figure 6: Consolidation of leading shares of the UK retail pharmacy market (%), 2009-14

Figure 7: Winners and losers in pharmacy market share (percentage point), 2014e on 2009

Figure 8: Pharmacy store numbers at financial year end, 2013

Figure 9: Changes in pharmacy store numbers, 2013/14 on 2008/09

Figure 10: Pharmacy sales density estimates (GBP/sq ft), 2013/14 and 2008/09

Figure 11: UK pharmacy store numbers, year-on-year change (%), 2009-14e

Figure 12: Opportunities from Walgreens Boots Alliance merger, 2014

Figure 13: Best One store fascia, 2014

Figure 14: Duane Reade new format developments, 2014

Figure 15: Pharmacy in Tesco Extra store, 2014

Figure 16: Big Four supermarkets' pharmacy numbers, 2009-14e

Figure 17: LloydsPharmacy European Pharmacy Network store, 2014

Figure 18: Superdrug pharmacy, 2014

Table 1: Retail pharmacy market definition, 2015

Table 2: Abbreviations and terms, 2015

Table 3: Retail pharmacy market, 2004-14e

Table 4: Retail pharmacy market by revenue source, 2004-14e

Table 5: NHS prescription items, dispensed volumes, 2004-14e

Table 6: Pharmacy market per capita, 2004-14e

Table 7: Changing population by age band, 2013, 2017 and 2022

Table 8: UK pharmacy store numbers, 2004-14e

Table 9: Number of pharmacies by type, 2009-14e

Table 10: Retail pharmacy market shares (%), 2009-14

Table 11: Market shares of NHS revenue (%), 2009-14

Table 12: OTC market shares (%), 2009-14

Table 13: Pharmacy sales density estimates (GBP/sq ft), 2009-14

Table 14: Major online pharmacies, 2014

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Insight Report,Retail,Drug Store and Health & Beauty stores,Verdict Retail

select a license
Single User License
USD 3450 INR 247641
Site License
USD 6900 INR 495282
Corporate User License
USD 10350 INR 742923



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]